Guggenheim initiated coverage on shares of Natera (NASDAQ:NTRA – Free Report) in a research report sent to investors on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $70.00 target price on the medical research company’s stock. Other equities analysts have also recently issued research reports about the company. Raymond James upgraded […]
Natera (NASDAQ:NTRA) Receives New Coverage from Analysts at Guggenheim etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
SWS Partners trimmed its holdings in Natera, Inc. (NASDAQ:NTRA – Free Report) by 1.0% in the 2nd quarter, HoldingsChannel reports. The fund owned 79,456 shares of the medical research company’s stock after selling 822 shares during the quarter. Natera makes up approximately 1.2% of SWS Partners’ holdings, making the stock its 14th biggest holding. SWS […]
Braidwell LP boosted its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 17.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,152,851 shares of the medical research company’s stock after purchasing an additional 170,610 shares during the quarter. Natera accounts for […]
State Board of Administration of Florida Retirement System grew its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 1.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 101,913 shares of the medical research company’s stock after buying […]